Metagenomi

About:

Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.

Website: https://www.metagenomi.co

Twitter/X: metagenomi

Top Investors: Bristol-Myers Squibb, Moderna, Ionis Pharmaceuticals, RA Capital Management, Bayer

Description:

Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development. The company's metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms. Metagenomi forges these naturally evolved systems into powerful gene editing systems that are ultra-small, extremely efficient, highly specific, and have a decreased risk of the immune response. Metagenomi's goal is to revolutionize gene editing for the benefit of patients around the world. The company was founded in 2018 and is headquartered in Emeryville, California.